期刊文献+

潜阳熄风胶囊治疗中风病先兆证85例临床观察

Qianyang Xifeng Capsule in Apoplexy Omen Syndrome Treatment:A report of 85 cases
下载PDF
导出
摘要 目的:观察潜阳熄风胶囊治疗中风病先兆证的疗效和安全性。方法:将155例中风病先兆证患者随机分为两组。治疗组85例给予潜阳熄风胶囊;对照组66例给予盐酸氟桂利嗪胶囊。1个月为1个疗程,3个疗程后观察两组患者的总体疗效、中医证候疗效、发作频次改善情况、血液流变学转化情况以及不良反应,并进行统计学分析。结果:治疗组综合疗效明显优于对照组(P<0.05)。结论:潜阳熄风胶囊治疗中风病先兆证具有整体作用优势。 Objective: To observe the curative effect and safety of Qianyang Xifeng Capsule on apoplexy omen syndrome. Methods:Totally 155 patients were randomized into two groups. The 85 patients of treated group with Qianyang Xifeng Capsule;the 66 patients of control group with Flanarizine Hydrochloride Capsules. A courses of treatment for a month, the total curative effect, TCM syndrome curative effect, the number of times reductive at occurrence, the amelioration in hemorheology, and the adverse re- action of two groups were observed and statistics analysis after three course of treatment. Results :The comprehensive curative effect of treated group was obvious better than that of control group(P 〈0. 05). Conclusion:It is superior that apoplexy omen syndrome was entire by Qianyang Xifeng Capsule.
出处 《辽宁中医杂志》 CAS 北大核心 2008年第10期1508-1509,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 河北省中医药管理局课题(05114)
关键词 中风病先兆证 血液流变学 潜阳熄风胶囊 中医药治疗 Apoplexy omen syndrome Hemorheology Qianyang Xifeng Capsule TCM therapy
  • 相关文献

参考文献3

二级参考文献37

  • 1Skalén K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature, 2002, 417: 750-754.
  • 2Joyce CW, Amar MJ, Lambert G, et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A, 2002, 99: 407-412.
  • 3Aiello RJ, Brees D, Bourassa PA, et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol, 2002, 22: 630-637.
  • 4van Eck M, Bos IS, Kaminskiet WE, al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A, 2002, 99: 6298-6303.
  • 5Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science, 2000, 289: 1524-1529.
  • 6Lee CH, Chawla A, Urbiztondo N, et al. Transcriptional repression of atherogenic inflammation: modulation by PPARδ. Science, 2003, 302: 453-457.
  • 7Libby P, Aikawa M, Schnbeck U. Cholesterol and atherosclerosis. Biochim Biophys Acta, 2000, 1529: 299-309.
  • 8Kwak BR, Mulhaupt F, Mach F. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins. Autoimmun Rev, 2003, 2: 332-338.
  • 9Llevadot J, Murasawa S, Kureishi Y, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest, 2001, 108: 399-405.
  • 10Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest, 2001, 108: 391-397.

共引文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部